A Study of Treatment Patterns and Clinical Outcomes of Psoriasis in Japan
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
A Study to Assess Safety of Nivolumab in Routine Oncology Practice in China
- Status
- COMPLETED
- Phase
- N/A
Anticoagulation Strategies for Acute Venous Thromboembolism in Patients With End-Stage Renal Disease Using USRDS Data
- Status
- COMPLETED
- Phase
- N/A
A Study to Assess the Safety and Tolerability of BMS-986158 Alone and in Combination With Either Ruxolitinib or Fedratinib in Participants With Blood Cancer (Myelofibrosis)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Subcutaneous Nivolumab Versus Intravenous Nivolumab in Participants With Previously Treated Clear Cell Renal Cell Carcinoma That is Advanced or Has Spread
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study in Participants With First-Line Nivolumab Plus Ipilimumb Therapy Combined With Two Cycles of Chemotherapy for Metastatic Non-Small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Exploratory Platform Trial to Evaluate Immunotherapy Combinations With Chemotherapy for the Treatment of Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Iberdomide Alone or in Combination With Dexamethasone for the Treatment of Intermediate- or High-Risk Smoldering Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Pediatric Participants With Moderate to Severe Plaque Psoriasis
- Status
- RECRUITING
- Phase
- PHASE3
A Study of Mavacamten in Participants With HFpEF and Elevation of NT-proBNP With or Without Elevation of cTnT
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-963272 in Participants With Nonalcoholic Fatty Liver Disease
- Status
- TERMINATED
- Phase
- PHASE1
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986308 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Nivolumab Combined With FOLFOX and Regorafenib in People Who Have HER2-Negative Esophagogastric Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986326 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Study of RP3 Monotherapy and RP3 in Combination With Nivolumab in Patients With Solid Tumours
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of CM24 in Combination with Nivolumab in Adults with Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Two Combination Treatment Regimens of Nivolumab and Ipilimumab in Patients With dMMR and / or MSI mCRC.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Bempegaldesleukin (BEMPEG: NKTR-214) in Combination With Nivolumab in Children, Adolescents and Young Adults With Recurrent or Treatment-resistant Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Ipilimumab With Nivolumab for Molecular-selected Patients With Castration-resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Chemoimmunotherapy for the Treatment of Men With Neuroendocrine or Aggressive Variant Metastatic Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2